Immunotoxins with increased activity against epidermal growth factor receptor vIII-expressing cells produced by antibody phage display

Clinical Cancer Research

Volumn 6, Issue 7, 2000, Pages 2835-2843

  Beers, Richard ^a   Chowdhury, Partha ^a   Bigner, Darell ^b   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOTOXIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CANCER IMMUNOTHERAPY; CYTOTOXICITY; DNA SEQUENCE; GLIOBLASTOMA; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL;

ADP RIBOSE TRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL TOXINS; CELL LINE; CELL SURVIVAL; CLONING, MOLECULAR; ESCHERICHIA COLI; EXOTOXINS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOTOXINS; MUTAGENESIS, SITE-DIRECTED; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECOMBINANT PROTEINS; SURFACE PLASMON RESONANCE; VIRULENCE FACTORS;

EID: 0033927216     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lorimer, I. A. J., Keppler-Hafkemeyer, A., Beers, R. A., Pegram, C. N., Bigner, D. D., and Pastan, I. Recombinant immunotoxins specific for a mutant epidermal growth factor receptor: targeting with a single chain antibody variable domain isolated by phage display. Proc. Natl. Acad. Sci. USA, 93: 14815-14820, 1996.
2. Lorimer, I. A. J., Wikstrand, C. J., Batra, S. K, Bigner, D. D., and Pastan, I. Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors. Clin. Cancer Res., 1: 859-864, 1995.
3. Wikstrand, C. J., Hale, L. P., Batra, S. K., Hill, M. I., Humphrey, P. A., Kurpad S. N., Mclendon, R. E., Moscatello, D., Pegram, C. N., Reist, C. J., Traweek, S. T., Wong, A. J., Zalutsky, M. R., and Bigner, D. D. Monoclonal-antibodies against EGFRvIII are tumor-specific and react with breast and lung carcinomas and malignant gliomas. Cancer Res., 55: 3140-3148, 1995.
4. Moscatello, D. K., Holgadomadruga, M., Godwin, A. K., Ramirez, G., Gunn, G., Zoltick, P. W., Biegel, J. A., Hayes, R. L., and Wong, A. J. Frequent expression of a mutant epidermal growth-factor receptor in multiple human tumors. Cancer Res., 55: 5536-5539, 1995.
5. Nishikawa, R., Ji, X. D., Harmon, R. C., Lazar, C. S., Gill, G. N., Cavenee, W. K., and Huang, H. J. S. A mutant epidermal growth-factor receptor common in human glioma confers enhanced tumorigenicity. Proc. Natl. Acad. Sci. USA, 91: 7727-7731, 1994.
6. Hwang, J., FitzGerald, D. J., Adhya, S., and Pastan, I. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in Escherichia coli. Cell, 48: 129-136, 1987.
7. Kreitman, R. J., Wilson, W. H., Robbins, D., Margulies, I., Stetler-Stevenson, M., Waldmann, T. A., and Pastan, I. Responses in refractory hairy cell leukemia to a recombinant immunotoxin. Blood, 10: 3340-3348, 1999.
8. Y monoclonal antibody B3. Clin. Cancer Res., 6: 1720-1739, 2000.
9. Pai, L. H., and Pastan, I. Clinical trials with Pseudomonas exotoxin immunotoxins. Clin. Appl. Immunotoxins, 234: 83-96, 1998.
10. Yelton, D. E., Rosok, M. J., Cruz, G., Cosand, W. L., Bajorath, J., Hellstron, I., Hellstrom, K. E., Huse, W. D., and Glaser, S. M. Affinity maturation of the BR96 anti-carcinoma antibody by codon-based mutagenesis. J. Immunol., 155: 1994-2004, 1995.
11. Barbas, C. F., and Burton, D. R. Selection and evolution of high-affinity human anti-viral antibodies. Trends Biotechnol., 14: 230-234, 1996.
12. Yang, W. P., Green, K., Pinzsweeney, S., Briones, A. T., Burton, D. R., and Barbas, C. F. CDR walking mutagenesis for the affinity maturation of a potent human anti-Hiv-1 antibody into the picomolar range. J. Mol. Biol., 254: 392-403, 1995.
13. Low, N. M., Holliger, P., and Winter, G. Mimicking somatic hypermutation: affinity maturation of antibodies displayed on bacteriophage using a bacterial mutator strain. J. Mol. Biol., 260: 359-368, 1996.
14. Dekruif, J., Boel, E., and Logtenberg, T. Selection and application of human single-chain Fv antibody fragments from a semisynthetic phage antibody display library with designed CDR3 regions. J. Mol. Biol., 248: 97-105, 1995.
15. Pini, A., Viti, F., Santucci, A., Carnemolla, B., Zardi, L., Neri, P., and Neri, D. Design and use of a phage display library. Human antibodies with subnanomolar affinity against a marker of angiogenesis eluted from a two-dimensional gel. J. Biol. Chem., 273: 21769-21776, 1998.
16. Wu, H. R., Beuerlein, G., Nie, Y., Smith, H., Lee, B. A., Hensler, M., Huse, W. D., and Watkins, J. D. Stepwise in vitro affinity maturation of Vitaxin, an α(v)β(3)-specific humanized mAb. Proc. Natl. Acad. Sci. USA, 95: 6037-6042, 1998.
17. Chowdhury, P. S., and Pastan, I. Improving antibody affinity by mimicking somatic hypermutation in vitro. Nat. Biotechnol., 17: 568-572, 1999.
18. Winter, G., Griffiths, A. D., Hawkins, R. E., and Hoogenboom, H. R. Making antibodies by phage display technology. Annu. Rev. Immunol., 12: 433-455, 1994.
19. McCafferty, J., Griffiths, A. D., Winter, G., and Chiswell, D. J. Phage antibodies-filamentous phage displaying antibody variable domains. Nature (Lond.) 348: 552-554, 1990.
20. Barbas, C. J., Kang, A. S., Lerner, R. A., and Benkovic, S. J. Assembly of combinatorial antibody libraries on phage surfaces. The gene-III site. Proc. Natl. Acad. Sci. USA, 88: 7978-7982, 1991.
21. MacCallum, R. M., Martin, A. C. R., and Thornton, J. M. Antibody-antigen interactions: contact analysis and binding site topography. J. Mol. Biol., 262: 732-745, 1996.
22. Neuberger, M. S., and Milstein, C. Somatic hypermutation. Curr. Opin. Immunol., 7: 248-254, 1995.
23. Jolly, C. J. The targeting of somatic hypermutation. Semin. Immunol., 8: 159-168, 1996.
24. Neuberger, M. S., Ehrenstein, M. R., Klix, N., Jolly, C. J., Yelamos, J., Rada, C., and Milstein, C. Monitoring and interpreting the intrinsic features of somatic hypermutation. Immunol. Rev., 62: 107-116, 1998.
25. Goyenechea, B., and Milstein, C. Modifying the sequence of an immunoglobulin V-gene alters the resulting pattern of hypermutation. Proc. Natl. Acad. Sci. USA, 93: 13979-13984, 1996.
26. Buchner, J., Pastan, I., and Brinkmann, U. A method for increasing the yield of properly folded recombinant fusion proteins-single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem., 205: 263-270, 1992.
27. Prior, T. I., FitzGerald, D. J., and Pastan, I. Barnase toxin: a new chimeric toxin composed of Pseudomonas exotoxin-A and barnase. Cell, 64: 1017-1023, 1991.
28. de Wildt, R. M. T., Hoet, R. M. A., van Venrooij, W. J., Tomlinson, I. M., and Winter, G. Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire. J. Mol. Biol., 285: 895-901, 1999.